Advanced search
Publication Cover
Acta Orthopaedica Volume 82, 2011 - Issue 6
Journal homepage
2,110
Views
100
CrossRef citations to date
0
Altmetric
Research Article

Survival and prognostic factors in chondrosarcoma

Results in 115 patients with long-term follow-up

Dimosthenis AndreouDepartment of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, BerlinCorrespondence[email protected]
,
Sebastian RuppinDepartment of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin
,
Sebastian FehlbergDepartment of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin
,
Daniel PinkDepartment of Hematology, Oncology and Palliative Care, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Bad Saarow, Bad Saarow
,
Mathias WernerDepartment of Pathology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Emil von Behring, Berlin, Germany
&
Per-Ulf TunnDepartment of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Berlin
Pages 749-755 | Received 21 Feb 2010, Accepted 04 Aug 2011, Published online: 09 Nov 2011

  • Bertoni F, Bacchini P, Hogendoorn PCW. Chondrosarcoma. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone ( Eds. Fletcher CDM, Unni KK, Mertens F). IARC Press, Lyon 2002.
  • Björnsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Primary chondrosarcoma of long bones and limb girdles. Cancer 1998; 83: 2105-19.
  • Bramer JA, Abudu AA, Grimer RJ, Carter SR, Tillman RM. Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer 2007; 43: 1944-51.
  • Brennan MF. The enigma of local recurrence. The Society of Surgical Oncology. Ann Surg Oncol 1997; 4: 1-12.
  • Brennan MF. Local recurrence in soft tissue sarcoma: more about the tumor, less about the surgeon. Ann Surg Oncol 2007; 14: 1528-9.
  • Campanacci M. Bone and soft tissue tumors, 2nd edn. Piccin Nuova Libraria, Padova 1999.
  • Dahlin DC, Henderson ED. Chondrosarcoma, a surgical and pathological problem; review of 212 cases. J Bone Joint Surg (Am) 1956; 38: 1025-38.
  • Delaney TF, Liebsch NJ, Pedlow FX, Adams J, Dean S, Yeap BY, McManus P, Rosenberg AE, Nielsen GP, Harmon DC, Spiro IJ, Raskin KA, Suit HD, Yoon SS, Hornicek FJ. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 2009; 74: 732-9.
  • Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer 1977; 40: 818-31.
  • Fiorenza F, Abudu A, Grimer RJ, Carter SR, Tillman RM, Ayoub K, Mangham DC, Davies AM. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg (Br) 2002; 84: 93-9.
  • Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovée JV. The clinical approach towards chondrosarcoma. Oncologist 2008; 13: 320-9.
  • Gitelis S, Bertoni F, Picci P, Campanacci M. Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg (Am) 1981; 63: 1248-57.
  • Gouin F, Ory B, Rédini F, Heymann D. Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival. Int J Cancer 2006; 119: 980-4.
  • Greene FL, Page DL, Fleming ID, Fritz A, Balch C, Haller D, Morrow M (eds.). AJCC Cancer Staging Manual. Springer-Verlag, New York 2002.
  • Gronchi A, Miceli R, Fiore M, Collini P, Lozza L, Grosso F, Mariani L, Casali PG. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann Surg Oncol 2007; 14 (5): 1583-90.
  • Healey JH, Lane JM. Chondrosarcoma. Clin Orthop 1986; (204): 119-29.
  • Heck RK Jr, Stacy GS, Flaherty MJ, Montag AG, Peabody TD, Simon MA. A comparison study of staging systems for bone sarcomas. Clin Orthop 2003; (415): 64-71.
  • Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 2005; 23: 559-68.
  • Klenke FM, Abdollahi A, Bertl E, Gebhard MM, Ewerbeck V, Huber PE, Sckell A. Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo. BMC Cancer 2007; 7: 49.
  • Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg AE, Jennings LC. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg (Am) 1999; 81: 326-38.
  • Leerapun T, Hugate RR, Inwards CY, Scully SP, Sim FH. Surgical management of conventional grade I chondrosarcoma of long bones. Clin Orthop 2007; (463): 166-72.
  • Morioka H, Weissbach L, Vogel T, Nielsen GP, Faircloth GT, Shao L, Hornicek FJ. Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res 2003; 9: 1211-7.
  • Pritchard DJ, Lunke RJ, Taylor WF, Dahlin DC, Medley BE. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer 1980; 45: 149-57.
  • Rizzo M, Ghert MA, Harrelson JM, Scully SP. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop 2001; (391): 224-33.
  • Schrage YM, Briaire-de Bruijn IH, de Miranda NF, van Oosterwijk J, Taminiau AH, van Wezel T, Hogendoorn PC, Bovée JV. Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment. Cancer Res 2009; 69: 6216-22.
  • Schrage YM, Machado I, Meijer D, Briaire-de Bruijn I, van den Akker BE, Taminiau AH, Kalinski T, Llombart-Bosch A, Bovée JV. COX-2 expression in chondrosarcoma: a role for celecoxib treatment? Eur J Cancer 2010; 46: 616-24.
  • Schwab JH, Wenger D, Unni K, Sim FH. Does local recurrence impact survival in low-grade chondrosarcoma of the long bones? Clin Orthop 2007; 462: 175-80.
  • Streitbürger A, Ahrens H, Balke M, Buerger H, Winkelmann W, Gosheger G, Hardes J. Grade I chondrosarcoma of bone: the Münster experience. J Cancer Res Clin Oncol 2009; 135: 543-50.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.